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LETTER TO THE EDITOR
Breast cancer and the pill - response to the letter from R.D.T. Farmer
Sir - Professor Farmer's lengthy critique of our study
naturally provokes us to respond in a spirited fashion. In so
doing, however, there is a risk that we might defend our
observations more robustly than we might wish, and with
greater emphasis that we had applied in the original paper.
The object of all research is ultimately to help in the
provision of the best care to our patients, and with this in
mind we feel that it is important to emphasise the main
conclusions of our paper. We could not explain all the
observations in satisfactory biological terms, nor could we
even attempt to discover why our results differed from those
of other positive studies and, more particularly, from those
which show no evidence of a link between breast cancer and
the pill. We therefore concluded that it was impossible at the
present time to determine whether or not there was any link
between use of oral contraceptives and the subsequent
development of breast cancer.
The overwhelming advantage of conducting natural
history studies through British general practitioners is that
they have a comprehensive knowledge of the morbidity,
treatment and mortality of their patients. They also have an
accurate knowledge of the necessary denominators, that is
the periods of observation, since they know when the
patients register and when they leave their practices. With
the ever-increasing mobility of populations, the method does
not avoid the possibility of substantial loss of subjects to
follow-up, particularly over long periods of time. This is a
disadvantage which we have always recognised and exten-
sively discussed. The question of whether such a loss to
follow-up could cause a bias has been discussed in every
paper that we have published, and we have been able to
conclude that such a bias is unlikely to have occurred. This
argument was presented in our breast cancer paper and,
clearly, Professor Farmer has missed it. There is no point in
repeating the discussion here.
It is also a disadvantage that we did not foresee the need
to record the age at which subjects had their first full-term
pregnancy. We did not claim that standardisation for parity
entirely corrected for this deficiency, we merely said that it
might reduce any such problem. While Professor Farmer
suggests that the known correlation between age at first
pregnancy and parity was determined in the 1960s in North
America, he believes that such a situation would not apply
to women in the UK in the 1970s and 1980s. We can see no
reason why they should not. Indeed, it is self-evident that in
any population in which the first birth occurs at an early age
the likelihood of additional pregnancies in those women
must be greater than in a population of women who have
their first birth at a late age. Our most important evidence
that age at first birth is unlikely to be confounding our
results is that there is no difference in the distribution of
ages at first birth between breast cancer cases who had used
the pill and those cases in women who had not.
Professor Farmer points out that our knowledge of cigar-
ette consumption has not been updated since the women
were recruited to the study in 1968-69. This is quite true,
and it would certainly have been helpful if we had been able
to collect reliable data at intervals throughout the study.
However, this proved impracticable. Since more women will
have stopped smoking in the past 20 years than will have
started, it follows that in our analyses of smoking habit there
is a likelihood that many women reported as smoking at the
time of particular disease occurrences will have been misclas-
sified and should have been classified as ex-smokers. The
result of this misclassification, as we have repeatedly empha-
sised in our publications, is that any effect of smoking is
underestimated in the study data. The most important issue,
however, is that there is no reason to believe that more
misclassification has occurred among OC ever-users than in
non-users. There was no evidence in our data of a correla-
tion between smoking and breast cancer. We agree that
because of the misclassification problem we may have over-
looked a true relationship. It is relevant, however, to remind
Professor Farmer that the effect of smoking (in spite of
misclassification) is strongly evident in relation to vascular
disease, and this indicates that our smoking data are by no
means useless (Royal College of General Practitioners, 1981,
1983; Croft & Hannaford, 1989).
We strongly disagree that the recording of social class
presents a similar problem. The categorisation of social class,
which is based upon the occupation of the head of the
household (and, therefore, in the context of our study on the
occupation of the husbands of the women) is a peculiarly
British phenomenon. It is intended to reflect, in the broadest
possible way, the lifestyles of the individuals so classified
and, indeed, is used as a proxy measure for that lifestyle.
For individuals the correlation is very poor, but it works
well for populations, and the larger the population the better
the correlations are sustained. It remains a very useful
measure which helps to explain differences in morbidity
patterns in different sections of the population, and many
other countries envy our ability to use it. Professor Farmer
implies that we would have been much better off if we had
knowledge of every change of occupation of the husbands of
the subjects in the study, and that we would thereafter have
reclassified them. In our view, such repetitive reclassification
would have obscured rather than illuminated our data, and
that it is not credible that such changes would have any
important effect on the lifestyle of the women, or that these,
in turn, could feasibly influence physiological and pathologi-
cal responses of the women concerned.
Table III of our paper shows the relationship between
parity and pill usage. Professor Farmer has taken this table
and calculated the risk ratios, as it were, vertically instead of
horizontally. He shows control subjects have a lowered risk
as a result of their first pregnancy, whereas ever-users do
not. Precisely! That is exactly the point of our table, but the
fact that we are able to show a strong dose-response effect
(duration of use) among users of parity 1 greatly increases
the likelihood that the observation is associated with pill
usage and, in this respect, we would place much more
emphasis on the highly significant trend rather than on the
individual values at different levels of duration of use.
Yours etc.,
C.R. Kay,
P.C. Hannaford,
The Royal College of General Practitioners,
Manchester Research Unit,
8 Barlow Moor Road,
Manchester M20 OTR, UK.
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